Early phase combined therapeutic management of acute ischaemic stroke

An adequate treatment of ischaemic stroke in the early phase (28-48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early de...

Full description

Saved in:
Bibliographic Details
Published in:Neurological sciences 2005-05, Vol.26 Suppl 1 (S1), p.S29-s30
Main Authors: Bassi, P, Lattuada, P, Tonietti, S
Format: Article
Language:English
Subjects:
Acute Disease
Brain Ischemia - drug therapy
Emergency Treatment
Fibrinolytic Agents - therapeutic use
Humans
Neurology
Neurosciences
Rehabilitation
Stroke
Thrombolytic Therapy - methods
Time Factors
Tissue Plasminogen Activator - therapeutic use
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An adequate treatment of ischaemic stroke in the early phase (28-48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated management of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.
ISSN:1590-1874
1590-3478
DOI:10.1007/s10072-005-0400-1